[go: up one dir, main page]
More Web Proxy on the site http://driver.im/ Skip to main content
Log in

Abnormal Intestinal Permeability in Primary Biliary Cirrhosis

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Antimitochondrial antibodies (AMAs) found in patients with primary biliary cirrhosis (PBC) cross-react with bacterial proteins and hence molecular mimicry has been proposed as a mechanism for AMA development. Alterations in gastrointestinal permeability would provide a potential route for increased exposure of gut flora to the immune system. In this study we aimed to compare the measured gastrointestinal permeability in patients with PBC to that in patients with liver disease (hepatitis C) and healthy control populations. Subjects drank a mixture of sucrose, lactulose, and mannitol dissolved in water. Eight-hour urinary excretion of the sugars was measured to assess intestinal permeability. Antiendomysial antibody testing was performed to exclude subclinical celiac disease. Eighty-six patients with PBC were evaluated and compared to 69 hepatitis C patients and 155 healthy controls. The mean urinary excretion of sucrose in the PBC patients (133.89 ± 72.56 mg) was significantly higher than that in hepatitis C patients (101.07±63.35) or healthy controls (89.46±41.76) (P=0.0001), suggesting abnormal gastric or proximal small intestinal permeability. Sucrose excretion was not increased among patients with hepatitis C compared to healthy controls. The ratio of lactulose:mannitol excretion, reflecting small bowel permeability, was also elevated in the PBC group (0.017±0.012) compared to healthy controls (0.012±0.007) (P=0.0001) but was equal to that found among patients with hepatitis C (0.016±0.011) (P=NS). We conclude that the permeability of both the stomach and the small bowel is increased in patients with PBC, however, it is unclear if it is a cause, consequence, or manifestation of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
£29.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lindenborn-Fotinos J, Baum H, Berg PA (1985) Mitochondrial antibodies in primary biliary cirrhosis: further characterization of the M2 antigen by immunoblotting revealing species and nonspecies specific determinants. Hepatology 5:763–769

    Article  PubMed  CAS  Google Scholar 

  2. Frazer IH, Mackay IR, Jordan TW, Whittingham S, Marzuki S (1985) Reactivity of antimitochondrial antibodies in primary biliary cirrhosis: definition of two novel mitochondrial polypeptide auto-antigens. J Immunol 135:1739–1745

    PubMed  CAS  Google Scholar 

  3. Fussey S, Lundsay J, Fuller C, Perham R, Dale S, James O, Bassendine M, Yeaman S (1991) Autoantibodies in primary biliary cirrhosis: analysis of reactivity against eukaryotic and prokaryotic 2-oxo acid dehydrogenase complexes. Hepatology 13:467–474

    Article  PubMed  CAS  Google Scholar 

  4. Yeaman S, Fussy S, Danner D, James O, Mutimer D, Bassendine M (1988) Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet 1:1067–1070

    Article  PubMed  CAS  Google Scholar 

  5. Fussey S, Guest J, James O, Bassendine M, Yeaman S (1988) Identification and analysis of major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci USA 85:8654–8658

    Article  PubMed  CAS  Google Scholar 

  6. Van de Water J, Frageau D, Davis P, Ansari A, Danner D, Leung P, Coppel R (1988) Autoantibodies of primary biliary cirrhosis (PBC) recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. J Immunol 141:2321–2324

    PubMed  CAS  Google Scholar 

  7. Surh C, Danner D, Ahmed A, Coppel R, Mackay I, Dickson E, Gershwin M (1989) Reactivity of primary biliary cirrhosis sera with a human fetal liver cDNA clone of branched-chain α-keto acid dehydrogenase dihydrolipoamide acetyltransferase, the 52 kD mitochondrial autoantigen. Hepatology 9:63–68

    Article  PubMed  CAS  Google Scholar 

  8. Fussey S, Bassendine M, Fittes D, Turner I, James O, Yeaman S (1989) The E1 α and β subunits of the pyruvate dehydrogenase complex are M2“d” and M2“e” autoantigens in primary biliary cirrhosis. Clin Sci 77:365–368

    PubMed  CAS  Google Scholar 

  9. Fregeau D, Roche T, Davis P Coppel R, Gershwin M (1990) Primary biliary cirrhosis: inhibition of pyruvate dehydrogenase complex activity by autoantibodies specific for E1α, a non-lipoic acid containing mitochondrial enzyme. J Immunol 144:1671–1676

    PubMed  CAS  Google Scholar 

  10. Fussey S, Ali S, Guest J, James O, Bassendine M, Yeaman S (1990) Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region. Proc Natl Acad Sci USA 87:3987–3991

    Article  PubMed  CAS  Google Scholar 

  11. Stemerowicz R, Moller B, Rodloff A, et al. (1988) Are antimitochondrial antibodies in primary biliary cirrhosis induced by R(rough)-mutants of Enterobacteriaceae? Lancet 2:1167–1170

    Google Scholar 

  12. Hopf U, Stemerowicz R, Rodloff A, Calanos C, Moller B, Hartmut L, Freudenberg M, Huhn D (1989) Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet 2:1419–1421

    Article  PubMed  CAS  Google Scholar 

  13. Burroughs A, Butler K, Brown D, Drumfitt W, Hamilton-Miller J, Baum H (1984) Bacteriuria and primary biliary cirrhosis. Gut 25:133–137

    Article  PubMed  CAS  Google Scholar 

  14. Morreale M, Tsirigotis M, Hughes MD, Brumfitt W, McIntyre N, Burroughs AK (1989) Significant bacteriuria has prognostic significance in primary biliary cirrhosis. J Hepatol 9(2):149–158

    Article  PubMed  CAS  Google Scholar 

  15. Kaplan M (1996) Primary biliary cirrhosis. N Engl J Med 21:1570–1580

    Article  Google Scholar 

  16. Niveloni, Dezi R, Pedreira S, Podesta A, Cabanne A, Vazquez H, Sugai E, Smecuol E, Doldan E, Valero J, Kogan Z, Boerr L, Maurino E, Terg R, Bai J (1998) Gluten sensitivity in patients with primary biliary cirrhosis. Am J Gastroenterol 93:404–408

    Article  PubMed  CAS  Google Scholar 

  17. Olsen R, Kagevi Y, Rydberd L (1982) On the concurrence of primary biliary cirrhosis and intestinal villous atrophy. Scand J Gastroenerol 17:625–628

    Article  Google Scholar 

  18. Primignani M, Carpinelli L, Preatoni P, et al. (2000) Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology 119:181–187

    Article  PubMed  CAS  Google Scholar 

  19. Smecuol E, Bai JC, Vazquez H, Kogan Z, Cabanne A, Niveloni S, Pedreira S, Boerr L, Maurino E, Meddings J (1997) Gastrointestinal permeability in celiac disease. Gastroenterology 112:1129–1136

    Article  PubMed  CAS  Google Scholar 

  20. Bjarnason I, MacPherson A, Hollander D (1995) Intestinal permeability: an overview. Gastroenterology 108(5):1566–1581

    Article  PubMed  CAS  Google Scholar 

  21. Vazquez H, Sugai E, Pedreira S, Katz S, Litwin N, De Rosa S, Ruiz J, Soifer G, Kogan Z Boerr L, Bai JC (1995) Screening for asymptomatic celiac sprue in families. J Clin Gastroentorol 21:130–133

    Article  CAS  Google Scholar 

  22. Budillon G, Parrilli G, Pacella M, Cuomo R, Menzies IS (1985) Investigation of intestine and liver function in cirrhosis using combined sugar oral loads. J Hepatol 1:513–524

    Article  PubMed  CAS  Google Scholar 

  23. Romiti A, Merli M, Martoarano M, Parrilli G, Martino F, Riggio O, Truscelli A, Capocaccia L, Budillon G (1990) Malabsorption and nutritional abnormalities in patients with liver cirrhosis. Ital J Gastroenterol 22:118–123

    PubMed  CAS  Google Scholar 

  24. Taylor RM, Bjarnason I, Cheeseman P, Davenport M, Baker AJ, Mieli-Vergani G, Dhawan A (2002) Intestinal permeability and absorptive capacity in children with portal hypertension. Scand J Gastroenterol 37:807–811

    Article  PubMed  CAS  Google Scholar 

  25. Giofre MR, Meduri G, Pallio S, Calandra S, Magnano A, Niceforo D, Cinquegrani M, di Leo V, Mazzon E, Sturniolo GC, Longo G, Fries W (2000) Gastric permeability to sucrose is increased in portal hypertensive gastropathy. Eur J Gastro 12:529–539

    Article  CAS  Google Scholar 

  26. De Leo V, Venturi C, Baragiotta A, Martines D, Floreani A (2003) Gastroduodenal and intestinal permeability in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 15:967–973

    Article  Google Scholar 

  27. Welsh F, Ramsden C, MacLennan K, Sheridan M, Barclay G, Guillou P, Reynolds J (1998) Increased intestinal permeability and altered mucosal immunity in cholestatic jaundice. Ann Surg 227:205–212

    Article  PubMed  CAS  Google Scholar 

  28. Smecuol E, Bai JC, Sugai E, Vazquez H, Niveloni S, Pedreira S, Maurino E, Meddings J (2001) Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs. Gut 49:650–655

    Article  PubMed  CAS  Google Scholar 

  29. Keshavarzian A, Fields J, Vaeth J, Holmes E (1994) The differing effects of acute and chronic alcohol on gastric and intestinal permeability. Am J Gastroenterol 89:2205–2211

    PubMed  CAS  Google Scholar 

  30. Fasano A, Budillon G, Guandalini S, Cuomo R, Parrilli G, Cangiotti AM, Morroni M, Rubino A (1990) Bile acids reversible effecs on small intestinal permeability. An in vitro study in the rabbi. Dig Dis Sci 35:801–808

    Article  PubMed  CAS  Google Scholar 

  31. Suenaert P, Bulteel V, Den Hond E, Hiele M, Peeters M, Monsuur F, Ghoos Y, Rutgeerts P (2000) The effects of smoking and indomethacin on small intestinal permeability. Aliment Pharmacol Ther 14:819–822

    Article  PubMed  CAS  Google Scholar 

  32. Blomquist L, Bark T, Hedenborg G, Norman A (1997) Evaluation of the lactulose/mannitol and 51Cr-ethylenediaminetetraacetic acid/14C-mannitol methods for intestinal permeability. Scand J Gastroenterol 32:805–812

    Article  PubMed  CAS  Google Scholar 

  33. Fukuda Y, Bamba H, Okui M, Tamura K, Tanida N, Satomi M, Shimoyama T, Nishigami T (2001) Helicobacter pylori infection increases mucosal permeability of the stomach and intestine. Digestion 63(Suppl 1):93–96

    Article  PubMed  Google Scholar 

  34. Spinzi G, Pellicano R, Minoli G, Terreni N, Cutufia MA, Fagoonee S, Rizzetto M, Ponzetto A (2001) Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. The Como cross-sectional study. Panminerva Med 43:85–87

    CAS  Google Scholar 

  35. Dohmen K, Shigematsu H, Miyamoto Y, Yamasaki F, Irie K, Ishibashi H (2002) Atrophic corpus gastritis and Helicobacter pylori infection in primary biliary cirrhosis. Dig Dis Sci 47:162–169

    Article  PubMed  Google Scholar 

  36. Floreani A, Biagini MR, Zappala F, Farinati F, Plebani M, Rugge M, Surrenti C, Naccarato R (1997) Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching. Ital J Gastroenterol Hepatol 29:13–17

    PubMed  CAS  Google Scholar 

  37. Yuhan R, Koutsouris A, Savkovic SD, Hecht G (1997) Enteropathogenic Escherichia coli-induced myosin light chain phosphorylation alters intestinal epithelial permeability. Gastroenterology 113:1873–1882

    Article  PubMed  CAS  Google Scholar 

  38. Kennedy RJ, Kirk SJ, Gardiner KR (2002) Mucosal barrier function and the commensal flora. Gut 50:441–442

    Article  PubMed  CAS  Google Scholar 

  39. Ma TY, Hollander D, Dadufalza V, Krugliak P (1992) Effect of ageing and caloric restriction on intestinal permeability. Exp Gerontol 27:321–333

    Article  PubMed  CAS  Google Scholar 

  40. Saweirs W, Andrews D, Low-Beer T (1985) The double sugar test of intestinal permeability in the elderly. Age Ageing 14:312–315

    Article  PubMed  CAS  Google Scholar 

  41. Bjarnson I, MacPherson A, Hollander D (1995) Intestinal permeability: an overview. Gastroenterology 108:1566–1581

    Article  Google Scholar 

  42. Meddings J (1997) Review article: Intestinal permeability in Crohn’s disease. Aliment Pharm Ther 11(Suppl 3):47–53

    Google Scholar 

  43. Parikh-Patel A, Gold EB, Worman H, Krivy KE, Gershwin ME (2001) Risk factors for primary biliary cirrhosis in a cohort of patients from the United States. Hepatology 33:16–21

    Article  PubMed  CAS  Google Scholar 

  44. Tsuneyama K, Van De Water J, Yamazaki K, Suzuki K, Sato S, Takeda Y, Ruebner B, Yost BA, Nakanuma Y, Coppel RL, Gershwin ME (1997) Primary biliary cirrhosis an epithelitis: evidence of abnormal salivary gland immunohistochemistry. Autoimmunity 26:23–31

    Article  PubMed  CAS  Google Scholar 

  45. Tsuneyama K, Van de Water J, Nakanuma Y, Cha S, Ansari A, Coppel R, Gershwin ME (1994) Human combinatorial autoantibodies and mouse monoclonal antibodies to PDC-E2 produce abnormal apical staining of salivary glands in patients with coexistent primary biliary cirrhosis and Sjogren’s syndrome. Hepatology 20(4, Pt 1):893–898

    Article  PubMed  CAS  Google Scholar 

  46. Nishio A, Keeffe EB, Gershwin ME (2002) Immunopathogenesis of primary biliary cirrhosis. Semin Liver Dis 22:291–302

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jordan J. Feld.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feld, J.J., Meddings, J. & Heathcote, E.J. Abnormal Intestinal Permeability in Primary Biliary Cirrhosis. Dig Dis Sci 51, 1607–1613 (2006). https://doi.org/10.1007/s10620-006-9544-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9544-z

Keywords

Navigation